T1	Participants 63 106	patients with differentiated thyroid cancer
T2	Participants 214 295	Slovak patients with differentiated thyroid cancer in Slovak and Czech hospitals.
T3	Participants 509 636	357 patients from the Slovak Republic with differentiated thyroid cancers (follicular and papillary) underwent complex therapy.